BR9911294B1 - complexo reversìvel de equilìbrio, preparação liofilizada, solução injetável e composição farmacêutica. - Google Patents

complexo reversìvel de equilìbrio, preparação liofilizada, solução injetável e composição farmacêutica. Download PDF

Info

Publication number
BR9911294B1
BR9911294B1 BRPI9911294-9A BR9911294A BR9911294B1 BR 9911294 B1 BR9911294 B1 BR 9911294B1 BR 9911294 A BR9911294 A BR 9911294A BR 9911294 B1 BR9911294 B1 BR 9911294B1
Authority
BR
Brazil
Prior art keywords
afp
aap
complex
complex according
solution
Prior art date
Application number
BRPI9911294-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9911294A (pt
Inventor
Oleg Strelchenok
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9911294A publication Critical patent/BR9911294A/pt
Publication of BR9911294B1 publication Critical patent/BR9911294B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI9911294-9A 1998-06-17 1999-06-17 complexo reversìvel de equilìbrio, preparação liofilizada, solução injetável e composição farmacêutica. BR9911294B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802162-9 1998-06-17
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (2)

Publication Number Publication Date
BR9911294A BR9911294A (pt) 2002-01-02
BR9911294B1 true BR9911294B1 (pt) 2012-01-10

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9911294-9A BR9911294B1 (pt) 1998-06-17 1999-06-17 complexo reversìvel de equilìbrio, preparação liofilizada, solução injetável e composição farmacêutica.

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
ATE243701T1 (de) * 1999-03-16 2003-07-15 Ardenia Investments Ltd Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
WO2002004467A1 (en) * 2000-07-12 2002-01-17 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
EP1085909A2 (en) 2001-03-28
EP1085909B1 (en) 2005-12-28
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
HK1035866A1 (en) 2001-12-14
BR9911294A (pt) 2002-01-02
AU748838B2 (en) 2002-06-13
SE9802162D0 (sv) 1998-06-17
JP2004500315A (ja) 2004-01-08
CA2335079A1 (en) 1999-12-23
WO1999065936A2 (en) 1999-12-23
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
CA2335079C (en) 2008-01-08
DE69929189T2 (de) 2006-08-31
DE69929189D1 (de) 2006-02-02
ATE314094T1 (de) 2006-01-15
US20010034324A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
Parker et al. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood
Kodama et al. Purification and characterization of a bovine acetyl low density lipoprotein receptor.
Levesque et al. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls
JP3810741B2 (ja) 修飾ｃ反応性タンパク質を使用する癌細胞検出用組成物
HU208161B (en) Process for producing cytotoxic active ingredient - antibody conjugates and pharmaceutical compositions
Cooper et al. In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum
US5500215A (en) Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
CA2215339C (en) Immunomodulating compositions from bile for the treatment of immune system disorders
CN112274656B (zh) 可将组合药物按比例递送至肿瘤组织的大环两亲自组装纳米颗粒的制备方法和应用
CN118203658A (zh) 一种重组抗Claudin18.2全人源单克隆抗体注射液制剂及制备方法
AU3426389A (en) Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof
US5824648A (en) Rnase-cv (coriolus versicolor)
BR9911294B1 (pt) complexo reversìvel de equilìbrio, preparação liofilizada, solução injetável e composição farmacêutica.
JP2002519303A (ja) 脂質動員性を有する糖タンパク質およびその治療的適用
Bouma et al. Synthesis and secretion of lipoproteins by human hepatocytes in culture
Bodenheimer Jr et al. Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells
RU2205010C2 (ru) Природные противоопухолевые или противовирусные вещества и их применение
JP3067212B2 (ja) 心臓の機能不全を治療する薬剤
CN110917139A (zh) 多分枝生物素修饰的乳腺癌靶向脂质体的制备和应用
FI80711B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar termiskt denaturerad, till en glykosidbindning ansluten antigen (gra), som haerroer sig fraon cancerceller.
US6087335A (en) RNase-CV (Coriolus versicolor)
HK1035866B (en) A complex of alpha-fetoprotein (afp) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
US4159320A (en) Activated MASF
MXPA00012558A (en) Composition for the treatement of immune deficiencies and methods for its preparation and use
US20090227488A1 (en) Class of bioactive glycoprotein

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/01/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2518 DE 09-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.